Accurate Detection of HPV Integration Sites in Cervical Cancer Samples Using the Nanopore MinION Sequencer Without Error Correction

During the carcinogenesis of cervical cancer, the DNA of human papillomavirus (HPV) is frequently integrated into the human genome, which might be a biomarker for the early diagnosis of cervical cancer. Although the detection sensitivity of virus infection status increased significantly through the Illumina sequencing platform, there were still disadvantages remain for further improvement, including the detection accuracy and the complex integrated genome structure identification, etc. Nanopore sequencing has been proven to be a fast yet accurate technique of detecting pathogens in clinical samples with significant longer sequencing length. However, the identification of virus integration sites, especially HPV integration sites was seldom carried out by using nanopore platform. In this study, we evaluated the feasibility of identifying HPV integration sites by nanopore sequencer. Specifically, we re-sequenced the integration sites of a previously published sample by both nanopore and Illumina sequencing. After analyzing the results, three points of conclusions were drawn: first, 13 out of 19 previously published integration sites were found from all three datasets (i.e., nanopore, Illumina, and the published data), indicating a high overlap rate and comparability among the three platforms; second, our pipeline of nanopore and Illumina data identified 66 unique integration sites compared with previous published paper with 13 of them being verified by Sanger sequencing, indicating the higher integration sites detection sensitivity of our results compared with published data; third, we established a pipeline which could be used in HPV integration site detection by nanopore sequencing data without doing error correction analysis. In summary, a new nanopore data analysis method was tested and proved to be reliable in integration sites detection compared with methods of existing Illumina data analysis pipeline with less sequencing data required. It provides a solid evidence and tool to support the potential application of nanopore in virus status identification.

[1]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[2]  Jianliu Wang,et al.  Dysregulation of host cellular genes targeted by human papillomavirus (HPV) integration contributes to HPV‐related cervical carcinogenesis , 2015, International journal of cancer.

[3]  Geir Kjetil Sandve,et al.  Transcriptionally Active Regions Are the Preferred Targets for Chromosomal HPV Integration in Cervical Carcinogenesis , 2015, PloS one.

[4]  Xiangmei Chen,et al.  Long‐distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region upregulating the allele‐specific MYC expression in HeLa cells , 2017, International journal of cancer.

[5]  Su-Cheng Huang,et al.  Integration of high-risk human papillomavirus DNA correlates with HLA genotype aberration and reduced HLA class I molecule expression in human cervical carcinoma. , 2005, Clinical immunology.

[6]  Chandra Sekhar Pedamallu,et al.  Characterization of HPV and host genome interactions in primary head and neck cancers , 2014, Proceedings of the National Academy of Sciences.

[7]  M. von Knebel Doeberitz,et al.  Detection of integrated papillomavirus sequences by ligation‐mediated PCR (DIPS‐PCR) and molecular characterization in cervical cancer cells , 2001, International journal of cancer.

[8]  Trevor J Pugh,et al.  Landscape of genomic alterations in cervical carcinomas , 2013, Nature.

[9]  L. Dinardo,et al.  Integration of Human Papillomavirus Genomes in Head and Neck Cancer: Is It Time to Consider a Paradigm Shift? , 2017, Viruses.

[10]  M. Machiela,et al.  Genomic characterization of viral integration sites in HPV‐related cancers , 2016, International journal of cancer.

[11]  B. Guinn,et al.  Urine Biomarkers for the Early Detection of Ovarian Cancer – Are We There Yet? , 2019, Biomarkers in cancer.

[12]  Chunhua Ma,et al.  Comparative study of HPV16 integration in cervical lesions between ethnicities with high and low rates of infection with high-risk HPV and the correlation between integration rate and cervical neoplasia. , 2015, Experimental and therapeutic medicine.

[13]  Yu Song,et al.  Simultaneous detection and comprehensive analysis of HPV and microbiome status of a cervical liquid-based cytology sample using Nanopore MinION sequencing , 2019, Scientific Reports.

[14]  Xiangyu Zhang,et al.  Long non-coding RNA GAS5 inhibits migration and invasion in gastric cancer via interacting with p53 protein. , 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[15]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[16]  W. J. Kent,et al.  BLAT--the BLAST-like alignment tool. , 2002, Genome research.

[17]  T. Carey,et al.  Human Papillomavirus Genome Integration and Head and Neck Cancer , 2018, Journal of dental research.

[18]  Chern Ein Oon,et al.  Key Molecular Events in Cervical Cancer Development , 2019, Medicina.

[19]  P. Hammerman,et al.  Genomic Landscape of Human Papillomavirus–Associated Cancers , 2015, Clinical Cancer Research.

[20]  Aiping Zhang,et al.  Characteristic of HPV Integration in the Genome and Transcriptome of Cervical Cancer Tissues , 2018, BioMed research international.

[21]  M. Frith,et al.  Adaptive seeds tame genomic sequence comparison. , 2011, Genome research.

[22]  Umesh Mahantshetty,et al.  HPV Genotyping and Site of Viral Integration in Cervical Cancers in Indian Women , 2012, PloS one.

[23]  Feng Luo,et al.  MECAT: fast mapping, error correction, and de novo assembly for single-molecule sequencing reads , 2017, Nature Methods.

[24]  Mile Šikić,et al.  Evaluation of hybrid and non-hybrid methods for de novo assembly of nanopore reads , 2015 .

[25]  X. Fang,et al.  Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism , 2015, Nature Genetics.

[26]  Francesca Giordano,et al.  Oxford Nanopore MinION Sequencing and Genome Assembly , 2016, Genom. Proteom. Bioinform..

[27]  Didier Peiffert,et al.  HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case report , 2019, BMC Cancer.

[28]  N. Coleman,et al.  Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis? , 2007, The Journal of pathology.

[29]  T. Ried,et al.  Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability , 2014, Genome research.

[30]  Fang Li,et al.  HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability , 2016, Journal of experimental & clinical cancer research : CR.

[31]  Edwin Cuppen,et al.  Mapping and phasing of structural variation in patient genomes using nanopore sequencing , 2017, Nature Communications.

[32]  Xin Chen,et al.  The characteristics of HPV integration in cervical intraepithelial cells , 2019, Journal of Cancer.

[33]  Hugo Alberto Barrera-Saldaña,et al.  Understanding the HPV integration and its progression to cervical cancer. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[34]  N Litviakov,et al.  HPV status and its genomic integration affect survival of patients with cervical cancer. , 2018, Neoplasma.

[35]  Li Fang,et al.  Detection of DNA base modifications by deep recurrent neural network on Oxford Nanopore sequencing data , 2019, Nature Communications.

[36]  Limei Chen,et al.  Identification of reliable biomarkers of human papillomavirus 16 methylation in cervical lesions based on integration status using high-resolution melting analysis , 2018, Clinical Epigenetics.

[37]  Guang-Rong Yan,et al.  N6-Methyladenine DNA Modification in Human Genome , 2017, bioRxiv.

[38]  C. Quince,et al.  Insight into biases and sequencing errors for amplicon sequencing with the Illumina MiSeq platform , 2015, Nucleic acids research.

[39]  A. Dutt,et al.  NGS-based approach to determine the presence of HPV and their sites of integration in human cancer genome , 2015, British Journal of Cancer.

[40]  Paul Horton,et al.  Parameters for accurate genome alignment , 2010, BMC Bioinformatics.

[41]  Koenraad Van Doorslaer,et al.  Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancer , 2019, bioRxiv.

[42]  Lars Jansen,et al.  Non-Random Integration of the HPV Genome in Cervical Cancer , 2012, PloS one.

[43]  Sung Ho Moon,et al.  Genomic characterization of clonal evolution during oropharyngeal carcinogenesis driven by human papillomavirus 16 , 2018, BMB reports.

[44]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[45]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[46]  Erin McKean,et al.  Integration of high‐risk human papillomavirus into cellular cancer‐related genes in head and neck cancer cell lines , 2017, Head & neck.

[47]  Magnus von Knebel Doeberitz,et al.  Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. , 2008, Cancer research.

[48]  T. Carey,et al.  Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma , 2016, Molecular Cancer Research.

[49]  Yang Ke,et al.  Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology , 2015, Oncotarget.

[50]  Jay Shendure,et al.  The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line , 2013, Nature.

[51]  Mirit I Aladjem,et al.  HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression , 2018, PLoS genetics.

[52]  Yang Ke,et al.  Genome-wide profiling of the human papillomavirus DNA integration in cervical intraepithelial neoplasia and normal cervical epithelium by HPV capture technology , 2016, Scientific Reports.

[53]  Shidong Xu,et al.  SEGF: A Novel Method for Gene Fusion Detection from Single-End Next-Generation Sequencing Data , 2018, Genes.

[54]  賢治 高橋,et al.  膵癌とlong non-coding RNA , 2016 .

[55]  Yanxiao Zhang,et al.  HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers , 2017, Molecular Cancer Research.

[56]  Xin Ma,et al.  Cytological Immunostaining of HMGA2, LRP1B, and TP63 as Potential Biomarkers for Triaging Human Papillomavirus-Positive Women , 2019, Translational oncology.

[57]  Michael Sammeth,et al.  Characterization of HPV integration, viral gene expression and E6E7 alternative transcripts by RNA-Seq: A descriptive study in invasive cervical cancer. , 2019, Genomics.

[58]  M. Pop,et al.  Sequence assembly demystified , 2013, Nature Reviews Genetics.

[59]  S. Vinokurova,et al.  Systematic Review of Genomic Integration Sites of Human Papillomavirus Genomes in Epithelial Dysplasia and Invasive Cancer of the Female Lower Genital Tract , 2004, Cancer Research.

[60]  Karolj Skala,et al.  Evaluation of hybrid and non-hybrid methods for de novo assembly of nanopore reads , 2015, bioRxiv.

[61]  Olivier Lantz,et al.  Human Papillomavirus Mutational Insertion: Specific Marker of Circulating Tumor DNA in Cervical Cancer Patients , 2012, PloS one.